Trial reportReproductive biology and endocrinology : RB&E2025
Feasibility and efficacy of random-start progestin-primed ovarian stimulation: a multicenter pilot randomized controlled trial in oocyte donation.
Trial report in Reproductive biology and endocrinology : RB&E, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03895099 (Feasibility and Efficacy of a New Ovarian Stimulation Regimen With RANDom Start, Use of Corifollitropin Alpha and Progestin Protocol for Oocyte donorS), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Feasibility and Efficacy of a New Ovarian Stimulation Regimen With RANDom Start, Use of Corifollitropin Alpha and Progestin Protocol for Oocyte donorS
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe aimed to assess the impact of the timing of ovarian stimulation initiation on the number of oocytes retrieved in a progestin-primed ovarian stimulation (PPOS) protocol for oocyte donors.
methodsA total of 110 oocyte donors were randomized in a multicenter, open-label, pilot randomized controlled trial conducted across four centers in France. Of these, 102 donors completed ovarian stimulation and underwent oocyte retrieval. Donors were assigned to start stimulation with corifollitropin alfa and oral desogestrel during one of five menstrual cycle phases: early follicular (EFP, Days 1–3), mid-follicular (MFP, Days 4–7), late follicular (LFP, Days 8–11), ovulatory (OP, Days 12–15), or luteal (LP, Days 16–30). Final oocyte maturation was triggered with triptorelin acetate. The primary endpoint was the total number of oocytes retrieved, with secondary outcomes including mature oocytes, premature LH surge, and ovarian hyperstimulation syndrome (OHSS).
resultsThe median age of donors was 33 years, with a mean BMI of 23.4 kg/m². The median number of retrieved oocytes was 11.5, with no significant differences between groups (p = 0.314). The median number of mature oocytes was 10, with no significant differences across groups. Given the limited statistical power inherent to pilot studies, an additional non-inferiority study was conducted. This subsequent analysis confirmed that the number of oocytes retrieved in the less previously studied and more challenging groups — the late follicular and ovulatory phases — was non-inferior to that observed in the reference group, defined as the early follicular phase. One donor in the mid-follicular phase had a premature LH surge (0.98%), and four cases of mild OHSS were reported (3.9%).
conclusionAccording to this pilot study, initiating PPOS with corifollitropin alfa at any phase of the menstrual cycle resulted in similar oocyte retrieval outcomes. This flexible approach is safe, effective, and offers potential benefits for donor management, patient convenience, and clinical workflow. Larger, adequately powered studies are required to validate these preliminary findings.
trial registrationClinicalTrials.gov Identifier: NCT03895099. Date of registration: March 28, 2019. First participant enrolled: September 4, 2020.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.